383 related articles for article (PubMed ID: 28888185)
1. Helicobacter pylori serological biomarkers of gastric cancer risk in the MCC-Spain case-control Study.
Fernández de Larrea-Baz N; Pérez-Gómez B; Michel A; Romero B; Lope V; Pawlita M; Fernández-Villa T; Moreno V; Martín V; Willhauck-Fleckenstein M; López-Abente G; Castilla J; Fernández-Tardón G; Dierssen-Sotos T; Santibáñez M; Peiró R; Jiménez-Moleón JJ; Navarro C; Castaño-Vinyals G; Kogevinas M; Pollán M; de Sanjosé S; Del Campo R; Waterboer T; Aragonés N
Cancer Epidemiol; 2017 Oct; 50(Pt A):76-84. PubMed ID: 28888185
[TBL] [Abstract][Full Text] [Related]
2. Helicobacter pylori seroprevalence in Spain: influence of adult and childhood sociodemographic factors.
Lorenzo I; Fernández-de-Larrea N; Michel A; Romero B; Lope V; Bessa X; Moreno V; Martín V; Amiano P; Castilla J; Tardón A; Dierssen-Sotos T; Peiró R; Díaz-Santos M; Navarro C; Jiménez-Moleón JJ; Butt J; Barricarte A; Ruiz I; Molina-de-la-Torre AJ; Casabonne D; Pérez-Gómez B; Kogevinas M; Del Campo R; de Sanjosé S; Pollán M; Waterboer T; Aragonés N
Eur J Cancer Prev; 2019 Jul; 28(4):294-303. PubMed ID: 30489354
[TBL] [Abstract][Full Text] [Related]
3. Opposing risks of gastric cardia and noncardia gastric adenocarcinomas associated with Helicobacter pylori seropositivity.
Kamangar F; Dawsey SM; Blaser MJ; Perez-Perez GI; Pietinen P; Newschaffer CJ; Abnet CC; Albanes D; Virtamo J; Taylor PR
J Natl Cancer Inst; 2006 Oct; 98(20):1445-52. PubMed ID: 17047193
[TBL] [Abstract][Full Text] [Related]
4. Antibody reactivity against Helicobacter pylori proteins in a sample of the Spanish adult population in 2008-2013.
Fernández-de-Larrea N; Michel A; Romero B; Butt J; Pawlita M; Pérez-Gómez B; Castaño-Vinyals G; Moreno V; Martín V; Amiano P; Castilla J; Fernández-Tardón G; Dierssen-Sotos T; Clofent J; Alguacil J; Huerta JM; Jiménez-Moleón JJ; Barricarte A; Molinuevo A; Fernández-Villa T; Casabonne D; Sierra Á; Kogevinas M; de Sanjosé S; Pollán M; Del Campo R; Waterboer T; Aragonés N
Helicobacter; 2017 Oct; 22(5):. PubMed ID: 28737284
[TBL] [Abstract][Full Text] [Related]
5. A CagA-independent cluster of antigens related to the risk of noncardia gastric cancer: associations between Helicobacter pylori antibodies and gastric adenocarcinoma explored by multiplex serology.
Song H; Michel A; Nyrén O; Ekström AM; Pawlita M; Ye W
Int J Cancer; 2014 Jun; 134(12):2942-50. PubMed ID: 24259284
[TBL] [Abstract][Full Text] [Related]
6. Helicobacter pylori infection and gastric atrophy: risk of adenocarcinoma and squamous-cell carcinoma of the esophagus and adenocarcinoma of the gastric cardia.
Ye W; Held M; Lagergren J; Engstrand L; Blot WJ; McLaughlin JK; Nyrén O
J Natl Cancer Inst; 2004 Mar; 96(5):388-96. PubMed ID: 14996860
[TBL] [Abstract][Full Text] [Related]
7. Multiplex H. pylori Serology and Risk of Gastric Cardia and Noncardia Adenocarcinomas.
Shakeri R; Malekzadeh R; Nasrollahzadeh D; Pawlita M; Murphy G; Islami F; Sotoudeh M; Michel A; Etemadi A; Waterboer T; Poustchi H; Brennan P; Boffetta P; Dawsey SM; Kamangar F; Abnet CC
Cancer Res; 2015 Nov; 75(22):4876-83. PubMed ID: 26383162
[TBL] [Abstract][Full Text] [Related]
8. Helicobacter pylori seropositivity and subsite-specific gastric cancer risks in Linxian, China.
Limburg P; Qiao Y; Mark S; Wang G; Perez-Perez G; Blaser M; Wu Y; Zou X; Dong Z; Taylor P; Dawsey S
J Natl Cancer Inst; 2001 Feb; 93(3):226-33. PubMed ID: 11158192
[TBL] [Abstract][Full Text] [Related]
9. Helicobacter pylori and CagA seropositivity and its association with gastric and oesophageal carcinoma.
Simán JH; Engstrand L; Berglund G; Forsgren A; Florén CH
Scand J Gastroenterol; 2007 Aug; 42(8):933-40. PubMed ID: 17613922
[TBL] [Abstract][Full Text] [Related]
10. Prospective study of Helicobacter pylori antigens and gastric noncardia cancer risk in the nutrition intervention trial cohort.
Murphy G; Freedman ND; Michel A; Fan JH; Taylor PR; Pawlita M; Qiao YL; Zhang H; Yu K; Abnet CC; Dawsey SM
Int J Cancer; 2015 Oct; 137(8):1938-46. PubMed ID: 25845708
[TBL] [Abstract][Full Text] [Related]
11. Helicobacter pylori blood biomarker for gastric cancer risk in East Asia.
Cai H; Ye F; Michel A; Murphy G; Sasazuki S; Taylor PR; Qiao YL; Park SK; Yoo KY; Jee SH; Cho ER; Kim J; Chen SC; Abnet CC; Tsugane S; Cai Q; Shu XO; Zheng W; Pawlita M; Epplein M
Int J Epidemiol; 2016 Jun; 45(3):774-81. PubMed ID: 27170766
[TBL] [Abstract][Full Text] [Related]
12. Prospective study of Helicobacter pylori biomarkers for gastric cancer risk among Chinese men.
Epplein M; Zheng W; Xiang YB; Peek RM; Li H; Correa P; Gao J; Michel A; Pawlita M; Cai Q; Shu XO
Cancer Epidemiol Biomarkers Prev; 2012 Dec; 21(12):2185-92. PubMed ID: 23035179
[TBL] [Abstract][Full Text] [Related]
13. Helicobacter pylori infection and low serum pepsinogen I level as risk factors for gastric carcinoma.
Kokkola A; Louhimo J; Puolakkainen P; Alfthan H; Haglund C; Rautelin H
World J Gastroenterol; 2005 Feb; 11(7):1032-6. PubMed ID: 15742409
[TBL] [Abstract][Full Text] [Related]
14. Helicobacter pylori and gastric lymphoma: high seroprevalence of CagA in diffuse large B-cell lymphoma but not in low-grade lymphoma of mucosa-associated lymphoid tissue type.
Delchier JC; Lamarque D; Levy M; Tkoub EM; Copie-Bergman C; Deforges L; Chaumette MT; Haioun C
Am J Gastroenterol; 2001 Aug; 96(8):2324-8. PubMed ID: 11513169
[TBL] [Abstract][Full Text] [Related]
15. [Helicobacter pylori CagA(+) infection in gastric cancer patients].
Ławniczak M; Starzyńska T
Pol Merkur Lekarski; 2002 Sep; 13(75):216-20. PubMed ID: 12474574
[TBL] [Abstract][Full Text] [Related]
16. Role of Helicobacter pylori CagA+ strains and risk of adenocarcinoma of the stomach and esophagus.
Wu AH; Crabtree JE; Bernstein L; Hawtin P; Cockburn M; Tseng CC; Forman D
Int J Cancer; 2003 Mar; 103(6):815-21. PubMed ID: 12516104
[TBL] [Abstract][Full Text] [Related]
17. Age and severity of mucosal lesions influence the performance of serologic markers in Helicobacter pylori-associated gastroduodenal pathologies.
Camorlinga-Ponce M; Flores-Luna L; Lazcano-Ponce E; Herrero R; Bernal-Sahagún F; Abdo-Francis JM; Aguirre-García J; Muñoz N; Torres J
Cancer Epidemiol Biomarkers Prev; 2008 Sep; 17(9):2498-504. PubMed ID: 18768521
[TBL] [Abstract][Full Text] [Related]
18. Meta-analysis of the relationship between cagA seropositivity and gastric cancer.
Huang JQ; Zheng GF; Sumanac K; Irvine EJ; Hunt RH
Gastroenterology; 2003 Dec; 125(6):1636-44. PubMed ID: 14724815
[TBL] [Abstract][Full Text] [Related]
19. Helicobacter pylori, pepsinogen, and gastric adenocarcinoma in Hawaii.
Nomura AM; Kolonel LN; Miki K; Stemmermann GN; Wilkens LR; Goodman MT; Perez-Perez GI; Blaser MJ
J Infect Dis; 2005 Jun; 191(12):2075-81. PubMed ID: 15897993
[TBL] [Abstract][Full Text] [Related]
20. Effect of Helicobacter pylori infection combined with CagA and pepsinogen status on gastric cancer development among Japanese men and women: a nested case-control study.
Sasazuki S; Inoue M; Iwasaki M; Otani T; Yamamoto S; Ikeda S; Hanaoka T; Tsugane S;
Cancer Epidemiol Biomarkers Prev; 2006 Jul; 15(7):1341-7. PubMed ID: 16835334
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
